Q&A With Pfizer: Progress On Vaccine, Next Steps, Covid-19 Challenges
Taking A Deep Dive With Dr. Phil Dormitzer, Vice President and Chief Scientific Officer for Viral Vaccines at Pfizer
Continue ReadingTaking A Deep Dive With Dr. Phil Dormitzer, Vice President and Chief Scientific Officer for Viral Vaccines at Pfizer
Continue ReadingTaking A Deep Dive With Dr. Phil Dormitzer, Vice President and Chief Scientific Officer for Viral Vaccines at Pfizer
Continue ReadingThe U.S.-based company, which is working alongside German drug maker BioNTech, said the first human participants in the U.S have been dosed with the potential vaccine, BNT162.
Continue ReadingDr. Phil Dormitzer, Vice President and Chief Scientific Officer for Viral Vaccines at Pfizer, Talks With RCBJ About Coronavirus
Continue Reading